Atlas Trials

Efficacy Study Of P276-00 In Subjects Of Malignant Melanoma Positive For Cyclin D1 Expression

Clinical trial NCT00835419 · COMPLETED

Trial details

NCT number
NCT00835419
Sponsor
Piramal Enterprises Limited
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Melanoma
Start date
2009-05-01
Primary completion
2011-04-01
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.